Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

The “morning-after pill” is available to a second generation at Jennifer’s home. “I have three teenagers, two boys and a girl, in the house,” she says, explaining that she keeps My Way (levonorgestrel) on hand. “Anyone who needs it can take it or give it to anyone else who does, including their friends.” Jennifer, now 41, benefited from having the pill when she was in her twenties and early thirties to avoid pregnancy after unprotected sex or potential failure of regular birth control. She took the pill first at 22, when her partner’s condom broke during intercourse, and then at…

Read More